Torben Bjerregaard Larsen (Torben B Larsen)

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 12

Top Topics

Venous Thromboembolism

Atrial Fibrillation

Oral Anticoagulants

Top Venues

Expert review of cardiovascular therapy

Clinical epidemiology

PharmacoEconomics - open

International journal of clinical practice

This page only lists publications with an associated author ORCID identifier.

Publications

Maja Thaarup, Peter Brønnum Nielsen, Anne Estrup Olesen, Maria Bitsch Poulsen, Torben Bjerregaard Larsen, Felix Wittström, Thure Filskov Overvad
Positive Predictive Value of Non-Traumatic Bleeding Diagnoses in the Danish National Patient Register. Clinical epidemiology 15 (2023)
Maja Thaarup, Peter Brønnum Nielsen, Anne Estrup Olesen, Maria Bitsch Poulsen, Torben Bjerregaard Larsen, Felix Wittström, Thure Filskov Overvad
Positive Predictive Value of Non-Traumatic Bleeding Diagnoses in the Danish National Patient Register. Clinical epidemiology 15 (2023)
Maja Thaarup, Peter Brønnum Nielsen, Anne Estrup Olesen, Maria Bitsch Poulsen, Torben Bjerregaard Larsen, Felix Wittström, Thure Filskov Overvad
Positive Predictive Value of Non-Traumatic Bleeding Diagnoses in the Danish National Patient Register. Clinical epidemiology 15 (2023)
Thure Filskov Overvad, Flemming Skjøth, Gregory Piazza, Simon Noble, Anne Gulbech Ording, Torben Bjerregaard Larsen, Peter Brønnum Nielsen
The Khorana score and venous and arterial thrombosis in patients with cancer treated with immune checkpoint inhibitors: A Danish cohort study. Journal of thrombosis and haemostasis : JTH 20 (12) (2022)
Marie Ørskov, Henrik Vorum, Torben Bjerregaard Larsen, Nanna Vestergaard, Gregory Y H Lip, Toke Bek, Flemming Skjøth
A review of risk factors for retinal vein occlusions. Expert review of cardiovascular therapy 20 (9) (2022)
Ida Ehlers Albertsen, Stavros V Konstantinides, Gregory Piazza, Samuel Z Goldhaber, Torben Bjerregaard Larsen, Mette Søgaard, Peter Brønnum Nielsen
Risk of Recurrent Venous Thromboembolism in Selected Subgroups of Men: A Danish Nationwide Cohort Study. TH open : companion journal to thrombosis and haemostasis 6 (4) (2022)
Olivia Wu, Stephen Morris, Torben Bjerregaard Larsen, Flemming Skjøth, Alex Evans, Kevin Bowrin, Piotr Wojciechowski, Wojciech Margas, Maria Huelsebeck
Effectiveness and Safety of Nonvitamin K Oral Anticoagulants Rivaroxaban and Apixaban in Patients with Venous Thromboembolism: A Meta-Analysis of Real-World Studies. Cardiovascular therapeutics 2022 (2022)
Sabine Michelsen Raunbak, Anne Sig Sørensen, Louise Hansen, Flemming Skjøth, Torben Bjerregaard Larsen, Lars Holger Ehlers
Cost Effectiveness of Patient Self-Managed Warfarin Compared with Direct Oral Anticoagulants in Atrial Fibrillation: An Economic Evaluation in a Danish Healthcare Sector Setting. PharmacoEconomics - open 6 (4) (2022)
Thure Filskov Overvad, Torben Bjerregaard Larsen, Mette Søgaard, Ida Ehlers Albertsen, Anne Gulbech Ording, Simon Noble, Anette Arbjerg Højen, Peter Brønnum Nielsen
Cancer-associated venous thromboembolism and the non-vitamin K antagonist oral anticoagulants: a review of clinical outcomes and patient perspectives. Expert review of cardiovascular therapy 18 (11) (2020)
Ida Ehlers Albertsen, Gregory Piazza, Mette Søgaard, Peter Brønnum Nielsen, Torben Bjerregaard Larsen
Extended oral anticoagulation after incident venous thromboembolism - a paradigm shift? Expert review of cardiovascular therapy 18 (4) (2020)
Flemming Skjøth, Henrik Vadmann, Søren Pihlkjaer Hjortshøj, Sam Riahi, Gregory Yoke Hong Lip, Torben Bjerregaard Larsen
Disease progression after ablation for atrial flutter compared with atrial fibrillation: A nationwide cohort study. International journal of clinical practice 72 (11) (2018)
Elin Danielsen Lunde, Peter Brønnum Nielsen, Sam Riahi, Torben Bjerregaard Larsen, Gregory Y H Lip, Kirsten Fonager, Mogens Lytken Larsen, Albert Marni Joensen
Associations between socioeconomic status, atrial fibrillation, and outcomes: a systematic review. Expert review of cardiovascular therapy 16 (11) (2018)